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I n Japan,  gender identity disorders have been diag-nosed and treated in accordance with Japan’s guide-
lines since 1996,  when various experts,  including psy-
chiatrists,  urologists,  gynecologists,  plastic surgeons,  
and psychotherapists,  joined in consultation to estab-
lish a standard diagnosis and treatment policy [1].  In 
addition,  since April 2018,  chest wall contouring sur-
gery for female-to-male transsexuals (FTMTS) has been 
partially covered by the national health insurance pol-
icy.  As a result of these advances,  the number of 
patients wishing to undergo this surgery is expected to 
increase.
In many FTMTS cases,  the natural contouring of the 
chest wall is different than in cisgender males and can be 
a major cause of mental stress.  The purpose of male-
type chest contouring surgery is to facilitate adaptation 
of the patient to the desired gender both personally and 
at a social level,  thereby reducing mental stress and 
improving sexual satisfaction.  Moreover,  a male-type 
chest wall cannot be obtained with breast reduction and 
hormone therapy alone.  For these reasons,  the vast 
majority of FTMTS wish to undergo male-type chest 
wall contouring,  including mastectomy and nipple 
reduction [2 , 3-7].
At our institution,  an algorithm assists in the selec-
tion of chest wall contouring surgeries and treatment 
policies to ensure that the most appropriate approach is 
chosen [8 , 9].  The key to this contouring surgery is to 
remove the surplus mammary gland tissue and skin,  
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Gender dysphoria is a condition in which a discrepancy between biological sex and gender identity causes dis-
tress.  Many female-to-male transsexuals (FTMTS) are uncomfortable with female breasts.  Chest wall contour-
ing surgery is effective for obtaining a male-type chest,  reducing mental stress,  and increasing sexual satisfac-
tion in such cases.  At the Okayama University Hospital Gender Center,  we have obtained positive results using 
an algorithm to determine the most appropriate surgical method for chest wall contouring in FTMTS patients.  
However,  serious complications requiring reoperation,  such as hematoma,  may still occur.  Postoperative 
hematomas were found in 15 (4.18%) of 358 FTMTS patients who underwent chest contouring surgery at our 
hospital between 2006 and 2018.  Postoperative hematoma was examined retrospectively.  The median time to 
the onset of hematoma was 7 (6-12) h after the initial surgery.  The main blood vessels causing bleeding were 
those in the head-side skin flap region where visual confirmation was difficult and the perforator vessels from 
the pectoralis major muscle.  Intraoperative bleeding and the operation time had a significant impact on the 
onset of postoperative hematoma.  This is the first retrospective study that investigated the blood vessels and 
other factors contributing to postoperative hematoma development after chest wall contouring.
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which are feminine features,  and reduce the nipple and 
the areola,  thereby obtaining a male-type chest wall 
outline without noticeable scarring.
Postoperative hematomas affect postoperative chest 
morphology and are serious complications that some-
times require reoperation.  However,  there have been 
no reports investigating the risk factors associated with 
the onset of postoperative hematoma after chest wall 
contouring.  To address this issue,  the present retro-
spective study examines the risk factors for postopera-
tive hematoma development.
Material and Methods
This study was approved by the Ethics Committee of 
Okayama University Hospital (Study No. 1808-030).  
The participants were 358 FTMTS who underwent chest 
wall contouring under general anesthesia at the 
Okayama University Hospital Gender Center between 
January 2006 and June 2018.  Informed consent was 
obtained from all study participants.
Since 2009,  the policy at the Okayama University 
Hospital Gender Center has been to classify breasts as 
Group 1 or Group 2 based on size,  and to determine 
the method of surgical treatment according to an algo-
rithm [12] (Fig. 1).  In Group 1,  the lowermost point of 
the areola ring edge was on the cephalic side of the 
inframammary line.  In Group 2,  the upper side of the 
areola was on the pedal side of the inframammary line,  
and breast ptosis was severe.  In Group 1,  regardless of 
the size of the areola,  a mastectomy was performed 
from the areola using a lower-half incision.  In Group 2,  
it was difficult to make a lower-half circumferential 
incision on the areola.  Therefore,  after the nipple and 
areola were collected as a composite graft,  the mam-
mary gland and skin were cut.  After the chest wall was 
formed,  the nipple and areola were then transplanted 
onto the chest wall as a composite graft [10-12].
One plastic surgeon performed the mastectomy and 
nipple and areola reductions on the left side,  and 
another plastic surgeon performed these operations on 
the right side.  In chest contouring surgery,  the mam-
mary gland tissue is excised above the fascia of the pec-
toralis major muscle,  leaving the mammary gland 
under the areola.  Adipose tissue surrounding the mam-
mary gland also affects the chest wall contour,  so it 
should also be resected.  In addition,  to preserve the 
blood flow to the areola,  the preservation of blood ves-
sels in the subcutaneous flap on the cephalic side is 
crucial [4-7 , 13].  Using a J-VACTM Drainage System 
(Ethicon,  Somerville,  NJ),  a 15 Fr.  BLAKETM Silicon 
Drain (Ethicon) was set subcutaneously on each side 
and connected to the J-VACTM suction reservoir.  
Postoperatively,  the chest wall was pressed and fixed 
with both a chest band and tape.  In all cases,  surgery 
was performed under general anesthesia,  and the hos-
pitalization period was 6 days.
Postoperative hematoma is a serious complication 
that requires emergency surgery [4-7].  Of the 358 cases 
of chest contouring surgery included in this study,  15 
resulted in postoperative hematoma.  A patient who 
developed pain,  development of purpura,  rapid swell-
ing,  and a blockage due to a blood clot in the indwell-
ing drain was diagnosed with a postoperative hema-
toma (Fig. 2).  We statistically examined all 15 cases 
using the remainder of the chest contouring surgery 
cases for which data could be obtained from medical 
records as a control group.  The factors examined 
included age,  body mass index (BMI),  history of hor-
mone treatment,  operation time,  intraoperative bleed-
ing volume,  smoking history,  bleeding site,  time to 
onset of postoperative hematoma,  weight of resected 
mammary gland,  and physical examination findings.  
In addition,  we examined the bleeding blocks of the 15 
cases and defined the bleeding regions caused by dam-
aged blood vessels anatomically (Fig. 3).
Statistical analyses were performed using BellCurve 
for Excel version 2.00 (Social Survey Research Informa-
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Group 1 Group 2
Fig. 1　 The algorithm used to determine the appropriate method 
for chest wall contouring surgery.
tion,  Tokyo).  Spearman’s correlation coefficient was 
calculated for the resected mammary gland weight and 
blood loss.  The surgical time and resected mammary 
gland weight were analyzed using a rank test.  
Wilcoxon’s signed rank test was used to compare the 
weights of the resected mammary glands on the hema-
toma and non-hematoma sides of patients who devel-
oped hematoma.  An unpaired t-test,  chi-square test,  
and Mann-Whitney U test were performed to determine 
the significance of age,  BMI,  mastectomy volume,  
bleeding volume,  initial surgery time,  hormonal ther-
apy history,  and smoking history.  Subsequently,  risk 
factors for postoperative hematoma were assessed with 
multiple logistic regression modeling.  A p-value of 0.05 
was considered significant.
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Fig. 2　 Postoperative hematoma on the right side after chest wall 
contouring surgery.
Fig. 3　 The main sources of the blood supply to the breast.  
Region (A) is a bleeding site arising from the residual mammary 
gland.  Region (B) is a site where bleeding was caused by blood 
vessels arising from the thoraco-acromial and intercostal arteries.  
Region (C) is a bleeding site caused by the subcutaneous blood 
vessel of the cephalic side arising from the lateral thoracic artery.  
Region (D) is a bleeding site caused by intercostal artery perforator 
vessels.  Region (E) is a bleeding site arising from the internal 
mammary artery perforator vessels.
Table 1　 Patient demographics in the famale to male group
Characteristics
Patients with hematoma onset 
(n=15)
Patients without hematoma onset 
(n=137) p
n % n %
Age,  mean (SD),  y 27.7 (6.0) 27.1 (6.2) ＞0.05
Body mass index,  mean (SD) kg/m2 23.0 (2.8) 22.3 (3.3) ＞0.05
Past smoker 4 26 73 53 ＞0.05
Medical History
　　asthma 3 20 14 10
Preoperative hormone therapya 14 93 119 86 ＞0.05
group1 14 93 134 97
group2 1 7 3 2
Initial operation time,  median (IQR),  minutes 145 (116-182) 130 (112.5-150) ＞0.05
Bleeding volume of
　　initial surgery,  median (IQR),  gram 40 (90-20) 15 (10-45) ＜0.05＊
Time to the onset of postoperative
　　hematoma,  median (IQR),  hours 7.0 (6.0-12)
aPreoperative hormonal therapy (cross sex hormone therapy)
 This number of the patients is that testosterone therapy had been used more than 3 months.
＊P＜0.05 (Mann-Whitneyʼs U test)
Results
The clinical backgrounds of the FTMTS population 
in the present investigation are shown in Table 1.  The 
intraoperative characteristics of chest contouring sur-
gery are shown in Fig. 4.  Operative time correlated with 
resected mammary gland weight (right side: r = 0.44,  
p < 0.005; left side: r = 0.39,  p < 0.005) (Fig. 5A).  
Intraoperative blood loss correlated with operative time 
(r = 0.40,  p < 0.005) (Fig. 5B).  Hematomas developed in 
15 of the 358 cases (4.2%).  Of these 15 cases,  14 
belonged to Group 1,  and 1 belonged to Group 2.  The 
age of the patients ranged from 19-44 years (mean 
27.7 ± 6.0).  The period from the initial surgery to the 
detection of the postoperative hematoma ranged from 2 
to 40 h after the surgery (median (IQR),  7.0 (6.0-12) 
h).  In all cases,  re-operation was performed within 3 h 
of detection of the postoperative hematoma.  Hema-
tomas were detected in 10 cases within 24 h,  in 2 cases 
within 24 to 48 h,  and in 3 cases more than 48 h after 
surgery.  During reoperation,  arterial bleeding occurred 
in 9 cases from the perforator vessels in the pectoralis 
major muscle and in 10 cases from subcutaneous vessels 
on the cephalic side flap.  In 14 cases,  hematomas 
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Fig. 4　 Delayed dilation of the subcutaneous blood vessel in the cephalic side skin ﬂap.
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Fig. 5　 (A) Scatter plot of the weight of the mammary gland versus the initial operative time (Spearmanʼs correlation: right side,  r=0.44,  
p＜0.005; left side,  r=0.39,  p＜0.005).  (B) Scatter plot of the estimated blood loss versus the initial operative time (Spearmanʼs correla-
tion: r=0.40,  p＜0.005).
occurred despite a drain being in place.  In 14 cases,  a 
clot was found in the lumen of the drain,  which was 
completely occluded (Fig. 2).  In one case,  a hematoma 
occurred in the vicinity of the drain insertion just after 
drain removal.
The bleeding site was localized to the right side in 10 
cases and to the left side in the other 5 cases.  Two cases 
involved bleeding from the residual mammary gland 
vessels under the areola (A),  9 cases involved bleeding 
from the perforator vessels over the pectoralis major 
muscle (B),  10 cases involved bleeding from the subcu-
taneous vessels on the cephalic flap side (C),  3 cases 
involved bleeding from the vessels of the lateral chest 
(D),  and 1 case involved bleeding from the vessels in 
the chest midline (E) (Table 2,  Fig. 3).  After hematoma 
removal surgery,  there were no cases that required fur-
ther additional surgery.  All patients were discharged on 
the 6th day after the first operation.
There were no cases in which a hematoma occurred 
simultaneously on both sides.  There was also no signif-
icant difference between the left and right weights of the 
excised mammary gland tissue of patients who had a 
hematoma (Wilcoxon signed-rank test; p > 0.05).  There 
was a significant difference between patients with and 
without hematomas in the initial intraoperative bleed-
ing volume,  but not in age,  BMI,  mastectomy volume,  
initial operation time,  hormonal therapy history,  or 
smoking history (Table 1).  Logistic regression analysis 
was performed,  including the weight of the excised 
mammary gland,  the initial operation time,  and the 
amount of bleeding at the initial operation as predictor 
variables.  The weight of the resected mammary glands 
and the initial operation time were significantly associ-
ated with the odds of developing a hematoma (Table 3).
Discussion
The weight of the mammary gland tissue correlated 
with the operation time,  and the operation time and 
intraoperative bleeding volume were also correlated 
(Fig. 5).  In addition,  because a significant difference 
was found in the amount of intraoperative bleeding 
between patients with a postoperative hematoma and 
those without one (Table 1),  it was initially predicted 
that the risk of postoperative hematoma would be high 
in patients with a large mammary gland (Fig. 5).  
However,  in the logistic regression analysis,  this pre-
diction was only born out for the left breast,  since there 
was a significant difference in the odds ratios of the 
weights of the right and left resected mammary glands 
with respect to the onset of hematoma (Table 3).
There were no predictable risk factors before surgery,  
and the only risk factors during surgery were an 
increase of intraoperative hemorrhage in univariate 
analysis,  mastectomy in multivariate analysis,  and pro-
longation of the operation time.  Case studies suggest 
that the larger the breast,  the greater the amount of 
intraoperative hemorrhage,  and the higher the risk of 
developing a hematoma (Table 1).  In other words,  the 
amount of intraoperative bleeding and extension of the 
operation time are risk factors for the development of 
October 2019 Hematoma after Chest Contouring 445
Table 2　 Postoperative hematoma development region
Region of blood vessels
　 causing hematoma n＝15 %
　　Region A 2 13
　　Region B 9 60
　　Region C 10 66
　　Region D 3 20
　　Region E 1 6
A: Residual mammary gland vessels under areola
B: Perforator vessels from pectoralis major muscle
C: Subcutaneous vessels on the cephalic ﬂap side
D: Vessels from the lateral chest
E: Vessels from the chest midline
Table 3　 Odds ratios for hematoma onset group
Odd ratios 95% CI p value
Weight of right mammary gland 0.96 0.93-0.98 .001＊
Weight of left mammary gland 1.04 1.01-1.06 .003＊
Initial operation time (minutes) 1.03 1.00-1.05 .015＊
Bleeding volume of initial surgery (gram) 1.01 1.00-1.02 .148　
CI,  conﬁdence interval.
＊p＜0.05 (Multivariate logistic regression analysis)
postoperative hematoma.  However,  in our multivariate 
analysis,  the smaller the weight of the right breast 
resection and the greater the weight of the left breast 
resection,  the higher the risk of developing a hema-
toma (Table 3).  In the case of the right breasts,  hema-
tomas may have occurred even in small breasts because 
it was difficult to obtain an operative field of view from 
a half circumferential incision of the areola in a small 
breast.  In our study,  one surgeon operated on left 
breasts and another on right breasts,  so the differing 
skills of the “left” and “right” surgeons may have 
affected the onset of hematoma.  Therefore,  when the 
bleeding site was examined,  the bleeding site showed a 
certain tendency,  and it is considered that defining the 
hemostatic site is a method of reducing the incidence of 
postoperative hematoma.
Regardless of breast size,  it is important to carefully 
confirm the hemostasis of blood vessels in regions (A) 
to (E) to prevent postoperative hematomas (Fig. 3).  We 
examined the cutting direction of the damaged blood 
vessels during the removal of mammary gland tissue.  In 
regions (B),  (D),  and (E),  it was necessary to cut the 
blood vessels vertically when peeling back the mam-
mary gland tissue,  which is thought to have caused 
bleeding from the blood vessel incisions.  In regions (A) 
and (C),  the mammary gland tissue was peeled perpen-
dicular to the direction of the blood vessels,  and it 
seemed that the blood vessels were damaged in the lon-
gitudinal direction and that hemorrhage occurred at 
multiple points.
Among all 15 hematoma cases,  regions (B) and (C) 
bled most frequently (Table 2).  In region (B),  the cut 
end of the blood vessel was easily buried in the pectora-
lis major muscle at the time of excision of the mammary 
gland; therefore,  it was difficult to obtain confirmation 
of hemostasis.  In region (C),  it was difficult to visually 
confirm the blood vessels traveling in the cephalic-side 
subcutaneous tissue,  and it seemed that bleeding in this 
region was caused by the longitudinal damage caused in 
the subcutaneous vessels when peeling away the mam-
mary gland and the subcutaneous tissue.  In some cases,  
dilation of the subcutaneous vessels of the cephalic side 
skin flap was observed around 30 min after mammary 
resection (Fig. 4).  Because of the postoperative changes 
in hemodynamics,  even if bleeding did not occur 
immediately after resection,  the remaining blood ves-
sels expanded over time,  bleeding from the vascular 
injury increased,  and a hematoma developed.
Hematomas usually develop approximately 7 h after 
surgery,  even if bleeding from drainage is not observed 
immediately after surgery.  It was confirmed during 
reoperation that the drain was clogged in 14 cases due to 
hematomas.  As the bleeding volume rapidly increased 
in a brief time period,  blood clots formed in the lumen,  
and the hematoma increased in size.
The limitations of this study include its retrospective 
nature and single-center design,  as there were only 15 
cases that experienced postoperative hematomas.
In conclusion,  there were no predictable risk factors 
before surgery.  Increased intraoperative bleeding and 
prolonged surgery are risk factors for the development 
of postoperative hematoma.  The operative skill of the 
surgeon also affects the onset of hematoma,  and it is 
believed that achieving reliable hemostasis at the hem-
orrhage site intraoperatively is a method of reducing the 
incidence of post-operative hematoma.
The bleeding sites that should be closely observed 
during surgery include the subcutaneous blood vessel 
on the cephalic side,  which is a blind spot,  and the per-
forator vessels emerging from muscles.  A hematoma 
can develop within 24 h after surgery,  and pain,  swell-
ing,  purpura,  and drainage volume should be carefully 
monitored during this time.
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